The global benign prostatic hyperplasia surgical treatment market was valued at USD 2,042.94 million in 2024 and is projected to grow at a 5.3% CAGR between 2025 and 2034 .A segmentation-based lens illustrates how procedure types, end‑user settings, and emerging technologies inform product differentiation, application‑specific growth, value chain optimization, and segment‑wise performance...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek